Rhiannon M. Doka

Works (1)

Updated: June 15th, 2023 22:12

2022 journal article

Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003–2017)

Journal of the American Veterinary Medical Association, 260(14), 1827–1833.

By: R. Doka n, S. Suter n, M. Mastromauro n , A. Bennett  n & P. Hess n 

MeSH headings : Dogs; Animals; Histiocytic Sarcoma / veterinary; Retrospective Studies; Dog Diseases / diagnosis; Doxorubicin / therapeutic use; Treatment Outcome
topics (OpenAlex): Veterinary Oncology Research; Infectious Diseases and Mycology; Oral and Maxillofacial Pathology
TL;DR: Benefits of doxorubicin administration in canine HS are modest, with a limited ORR and delay in tumor progression, and are comparable to effects attained with other single-agent regimens. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
1. No Poverty (OpenAlex)
Sources: Web Of Science, NC State University Libraries, ORCID, Crossref
Added: February 6, 2023

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.